Drug Database · Clinicians

Lactulose

Brands (60) Lactusaph, Laxipate, Accellac…Show all

Osmotic Laxative (Osmotic Activity; Acidifying Activity) US FDA class
Laxative/ cathartic; Laxative (osmotically acting); and others PH FDA category

Rx · Prescription drugOTC · Over-the-counter66 PH productsPNF-listed
Dispensing: Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 3363bdbd-f0d1-45b3-8193-7fdb0a310cc2, version date October 15, 2026 (Lactulose · Foxland Pharmaceuticals, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE LACTULOSE For Oral Solution is indicated for the treatment of constipation.
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE LACTULOSE For Oral Solution is indicated for the treatment of constipation. In patients with a history of chronic constipation, lactulose therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.

Contraindications

CONTRAINDICATIONS Since LACTULOSE For Oral Solution contains galactose (less than 0.3 g/10 g as a total sum with lactose), it is contraindicated in patients who require a low galactose diet.

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION The usual adult dosage is 10 g to 20 g of lactulose daily. The dose may be increased to 40 g daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement. DIRECTIONS FOR PREPARATION Dissolve contents of packet in half a glass (4 ounces) of water. When Lactulose For Oral Solution is dissolved in water, the resulting solution may be colorless to a slightly pale yellow color.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Pediatric

Pediatric use (US label) US FDA label

Pediatric Use Safety and effectiveness in pediatric patients have not been established.

Dosage forms

Philippines

  • Oral solution: 3.33 g per 5 mL, 3.33 g/5 mL, 3.35 g/5 mL, 10 g/15 mL
  • Syrup: 3.3 g per 5 mL, 3.3 g/5 mL, 3.33 g/5 mL, 3.35 g/5 mL, 3.35 mg/5 mL
  • ) oral solution: 3.3 g/5 mL (10 g/15 mL, 3.33 g/5 mL (10 g/15 mL, 10 g/15 mL (3.33 g/5 mL, 670 mg/mL (3.35 g/5 mL

Registered products in the Philippines

66 products registered with the Food and Drug Administration (FDA) Philippines list Lactulose as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products66
Philippine FDA-registered products for Lactulose
Package insert
AccellacLactulose
3.35g /5mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Accesspoint International Trading Inc.
DRP-4815
Feb 10, 2032
ActilaxLactulose
670 mg/mL (3.35 g/5 mL) Oral SolutionOpaque White PET Bottle x 100 mL (Box of 1's)
Rx
Zee LaboratoriesIndia
Importer: Eon Pharmatek Inc.
DR-XY47613
Dec 17, 2031
AdocLactLactulose
10 g/15 mL (3.33 g/5 mL) Oral SolutionAmber-colored PET Bottle sealed with 25 mm PP cap x 100 mL (Box of 1's)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Genedrift Philippines OPC
DRP-16033
Oct 18, 2029
AelacLactulose
3.35 g/5 ml Oral SolutionAmber PET Bottle with ROPP cap x 100 ml + Measuring cup (Box of 1's)
Rx
PANACEA BIOTEC PHARMA LIMITEDIndia
DYNASTY PHARMACEUTICALSImporter: Medinova Pharmaceutical Inc.
DRP-12458-01
Aug 12, 2027
AlvolaxusLactulose
3.3 g/5 mL (10 g/15 mL) Oral SolutionPET/Alu/PE Sachet foil x 15 mL (Box of 20's)
Rx
Fresenius Kabi Austria GmbHAustria
METRO DRUG, INC.Trader: Alvogen Asia Pacific Holdings Limited
DR-XY45868
May 31, 2027
AvolacLactulose
3.35 g/5 mL Oral SolutionWhite PVDC Plastic Bottle x 100 mL and 200 mL
Rx
Aristopharma Ltd.Bangladesh
Sahar International Trading Inc.
DR-XY42042
May 24, 2028
B-LactLactulose
3.35 g/5 mL SyrupAmber Glass Bottle x 120 mL with Measuring Cup (Box of 1's)
Rx
Fresenius Kabi Austria GmbHAustria
Sahar International Trading, Inc.Importer: Sahar International Trading Inc.Trader: Brookes Pharma (Private) Limited
DRP-5264
Apr 5, 2028
BIOLACLactulose
3.33 g/5 mL Oral SolutionAmber PET Bottle x 120 mL (Box of 1's)
Rx
UNITED BIOTECH PVT. LTD.India
TRIPLE TACT IMPORT & EXPORT CORP.
DRP-7545
Oct 3, 2028
ConsiloseLactulose
3.33 g per 5 mL Oral SolutionAmber Colored PET Bottle x 120 mL (Box of 1's)
Rx
Scott-Edil Pharmacia LimitedIndia
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5413-01
Aug 4, 2029
ConstilaxLactulose
10 g/15 mL (3.33 g/5 mL) Oral SolutionAmber PET bottle x 120 mL with ROPP cap + 15 mL PP measuring cup (Box of 1's)
Rx
Wallace Pharmaceuticals Pvt. Ltd.India
Hexagon Pharmaceuticals
DRP-16032
Oct 18, 2029
DixiloseLactulose
3.33 g/5 mL Oral Solution
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-9124-06
Sep 4, 2030
DolacLactulose
10 g/15 mL (3.33 g/5 mL) Oral Solution120 mL and 200 mL Polyethylene Bottle [Box of 1's]
Rx
Rhydburg Pharmaceuticals LimitedIndia
Genedrift Philippines OPC
DRP-13533
Mar 8, 2028
DuphalacLactulose
3.3 g/ 5 mL SyrupAmber bottle 45mL and 120mL
OTC
Abbott Healthcare Products B.V.Netherlands
Zuellig Pharma CorporationTrader: Abbott Laboratories
DRP-222
Mar 31, 2027
Duphalac MomLactulose
3.3g/5mL Syrup (Plum-flavored)White Opaque HDPE Blow-mould Bottle with Tamper-evident White Opaque PP Screw Cap and Translucent PP Measuring Cup x 200mL (Box of 1's)
OTC
Abbott Biologicals B.V.Netherlands
Importer: Abbott Laboratories
DR-XY46203
Dec 28, 2027
DylacLactulose
3.33 g/5 mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's)
Rx
Magbro Healthcare Pvt. LtdIndia
Dynasty PharmaceuticalsImporter: Pharmakon Biotec Inc
DRP-9124-11
Sep 4, 2030
EasylacLactulose
3.35 g/5 mL Oral SolutionAmber PET Bottle With ROPP cap x 100 mL + measuring cup (Box of 1’s)
Rx
Panacea Biotec Ltd.India
Medinova Pharmaceutical Inc.
DRP-12458
Aug 12, 2027
EasyloozLactulose
3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cup x 120 mL (Box of 1's)
Rx
Stallion Laboratories Pvt. Ltd.India
Danzz Pharma Marketing Inc.Importer: Ambica International Corporation
DRP-9183-02
Sep 30, 2030
GeolacLactulose
3.35 g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) Ltd.Pakistan
Geo Pak International Trading Corp.Importer: Accesspoint International Trading Inc
DRP-4815-02
Feb 10, 2027
GolactuloseLactulose
3.33 g/5 mL Oral Solution
Rx
Magbro Healthcare Pvt. Ltd.India
Applied Pharmaceutical Distribution Inc.Importer: Pharmakon Biotec Inc
DRP-9124-12
Sep 4, 2030
HailacLactulose
3.33 g/5 mL Oral SolutionAmber PET Bottle x 120 mL (Box of 1's)
Rx
UNITED BIOTECH PVT. LTD.India
GREENCORE PHARMA INC.Importer: TRIPLE TACT IMPORT & EXPORT CORP.
DRP-7545-01
Oct 3, 2028
KleenlacLactulose
3.35 g/5 mL Syrup.60 mL and 120 mL Amber Glass Bottle (Box of 1's)
Rx
Nabiqasim Industries (Pvt.) Ltd.Pakistan
Accesspoint International Trading, Inc.
DRP-14641
Nov 9, 2028
Laclose ProLactulose
3.33g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-9124-15
Sep 4, 2030
LACTOBURGLactulose
3.33 g/5 mL Oral SolutionPET amber plastic bottle x 120 mL in a monocarton and 200 mL in a monocarton (Box of 1's)
Rx
Rhydburg Pharmaceuticals Ltd.India
Sanimed Pharmaceuticals Inc.
DRP-10806
Nov 25, 2031
LactokhrizLactulose
3.33 g/5 mL Oral SolutionPET Amber plastic bottle x 60 mL, 120 mL, and 200 mL (Box of 1's)
Rx
Rhydburg Pharmaceuticals Ltd.India
Khriz Pharma Trading, Inc.
DRP-10807
Nov 25, 2031
LactopenLactulose
3.33 g/5 mL Oral SolutionPET amber plastic bottle x 60mL, 120 mL and 200 mL (Box of 1's)
Rx
Rhydburg Pharmaceuticals Ltd.India
A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading, Inc.
DRP-10807-01
Nov 25, 2026
LactosanLactulose
3.33 g/ 5 mL Oral SolutionPET amber plastic bottle x 120 mL in a monocarton and 200 mL in a monocarton (Box of 1's)
Rx
Rhydburg Pharmaceuticals Ltd.India
Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc.
DRP-10806-01
Nov 25, 2026
LactowynLactulose
10g/15mL Oral Solution120 mL amber colored PET bottle with silver cap + 10 mL measuring cap (Box of 1's)
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.
DR-XY47799
Mar 10, 2027
LactucareLactulose
3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Euro-Care Products PhilippinesImporter: Accesspoint International Trading Inc.
DRP-4815-06
Feb 10, 2027
LactudenLactulose
3.33 g/5 mL Oral Solution
Rx
Magbro Healthcare Pvt. Ltd.India
Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-9124-10
Sep 4, 2030
LactueaseLactulose
3.33 g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's)
Rx
Magbro Healthcare Pvt. Ltd.India
Vitalife Pharma & Medical Supply Inc.Importer: Pharmakon Biotec Inc.
DRP-9124-16
Sep 4, 2030
LactulLactulose
3.35g/5mL Oral Solution100 mL PET Plastic Amber Colored Bottle
Rx
Y.S.P. Industries (M) Sdn. Bhd.Malaysia
Yung Shin (Philippines), Inc.
DR-XY32453
Oct 18, 2031
LactulifeLactulose
3.35 g/5 mL Syrup30 Ml, 45 Ml, 60 Ml, And 120 Ml Pet Round Amber Bottle With white ROPP Aluminum Cap (Box of 1's)
Rx
Nucare Labs LLPIndia
Biophil Medical Equipment and Supplies Trading
DRP-18548
Jul 29, 2031
LactunavLactulose
3.33 g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's)
Rx
Magbro Healthcare Pvt. Ltd.India
JNC Pharmaceuticals CorporationImporter: Pharmakon Biotec Inc.
DRP-9124-14
Sep 4, 2030
LactusaphLactulose
3.33 g/5 mL Syrup20 mL-capacity USP Type I Clear Colorless Glass Vial with Bromobutyl Rubber Stopper and Aluminum Flip-off Seal (Box of 1's)
Rx
Enicar Pharmaceuticals Pvt. Ltd.India
Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-13607
Mar 17, 2028
LactusaphLactulose
3.35 mg/5 mL Syrup30 mL, 45 mL, 60 mL and 120 mL PET Round Amber Bottle
Rx
Azine Healthcare Pvt. Ltd.India
Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-11001
Dec 31, 2026
LactuSaveLactulose
3.35 g / 5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 ml and 120ml (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Savelink Pharma and Trading Co.Importer: Accesspoint International Trading Inc.
DRP-4815-09
Feb 10, 2027
LactusolLactulose
3.35g/5mL Oral Solution120 mL PET amber bottle with HDPE screw cap (Box of 1’s)
Rx
KCK Pharmaceutical Industries Sdn. Bhd.Malaysia
Endure Medical, Inc.
DR-XY48279
Aug 12, 2027
LaxedilLactulose
3.33 g per 5 mL Oral SolutionAmber colored PET Bottle x 120 mL (Box of 1's)
Rx
Scott-Edil Pharmacia LimitedIndia
Cyden Medicale Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-5413
Aug 4, 2029
LaxfreeLactulose
3.3 g per 5 mL SyrupAmber Coloured PET Bottle x 120 mL (Box of 1's)
Rx
Stallion Laboratories Pvt. Ltd.India
Orange Biotec Inc.Trader: Mac Heal Laboratories Ltd.
DRP-9547
Apr 15, 2029
LaxigenLactulose
10g/15 mL (3.33 g/5 mL) Oral Solution120 mL and 200 mL Polyethylene Bottle [Box of 1's]
Rx
Rhydburg Pharmaceuticals LimitedIndia
Tazio Lifescience Inc.Importer: Pharmastar Int'l Trading Corp.
DRP-13533-02
Mar 8, 2028
LaxipateLactulose
3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cup x 120 mL (Box of 1's)
Rx
Stallion Laboratories Pvt. Ltd.India
The Cathay Drug Co., Inc.Importer: Ambica International Corporation
DRP-9183-03
Sep 30, 2030
LaxipateLactulose
3.35 g/ 5 mL Syrup (Caramel Flavor)PET round amber bottle with white aluminum cap and measuring cup x 120 mL (Box of 1's)
Rx
Azine Healthcare Pvt. Ltd.India
The Cathay Drug Co., Inc.Importer: Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-11001-01
Dec 31, 2026
LaxitolLactulose
10 g/15 mL (3.33g/5mL) Oral Solution120 mL and 200 mL Polyethylene Bottle (Box of 1's)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Healthwinds Medical Trading CorpImporter: Pharmastar Int'l Trading Corp.
DRP-13533-01
Mar 8, 2028
LaxolLactulose
3.33 g/5 mL (10 g/15 mL) Oral Solution120 mL PET Bottle (Box of 1's)
Rx
Rhydburg Pharmaceuticals LimitedIndia
Endure Medical, Inc.
DRP-XY49432
Jun 30, 2030
LaxoseLactulose
3.35 g/5 mL SyrupAmber Glass Bottle with measuring cup x 100mL (Box of 1's)
Rx
Biopharma Laboratories LimitedBangladesh
JF Draf Pharmaceuticals Corporation
DRP-6207
Jun 29, 2030
LilacLactulose
3.35 g/5 mL SyrupAmber-colored PET Bottle of 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) Limited.Pakistan
Getz Pharma (Phils.), Inc.Trader: Getz Pharma (Pvt.) Ltd.
DR-XY41630
Jul 21, 2030
LivalacLactulose
3.3g/5mL SyrupType II Amber Glass Bottle Sealed with White Aluminum Cap x 100mL (Box of 1's)
Rx
Olic (Thailand) LimitedThailand
Paradigm Pharma (Philippines) Corporation
DRP-16637
May 23, 2030
MegalaxLactulose
3.33 g per 5 mL Oral SolutionAmber Colored PET Bottle x 120 mL (Box of 1's)
Rx
Scott-Edil Pharmacia LimitedIndia
Meganorth PharmaImporter: Pharmakon Biotec Inc.
DRP-5413-04
Aug 4, 2029
MovelaxLactulose (as Lactulose Concentrate)
3.3 g/5 mL SyrupAmber Glass Bottle with Aluminum Pilfer-Proof x 120 mL and 30 mL (Box of 1's)
Rx
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, INC.
DR-XY37503
Apr 12, 2031
NoneLactulose
3.33 g/5 mL Oral SolutionAmber PET Bottle x 120 mL (Box of 1's)
Rx
UNITED BIOTECH PVT. LTD.India
TGP PHARMA INC.Importer: TRIPLE TACT IMPORT & EXPORT CORP.
DRP-7545-02
Oct 3, 2028
NoneLactulose
3.35 g/5 mL Oral SolutionAmber PET Bottle x 120 mL with HDPE screw cap and medicine cup (Box of 1's)
OTC
KCK Pharmaceutical Industries Sdn. Bhd.Malaysia
TGP Pharma Inc.Importer: GreenCore Pharma Inc.
DRP-13301-01
Jan 20, 2028
NoneLactulose
3.35g / 5mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Reta DrugImporter: Accesspoint International Trading Inc.
DRP-4815-08
Feb 10, 2027
One-LactLactulose
3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt) LtdPakistan
One-Dexcel Pharma Inc.Importer: Accesspoint International Trading, Inc.
DRP-4815-03
Feb 10, 2027
PeptoburgLactulose
3.33 g/5 mL Oral SolutionPET amber plastic bottle x 120 mL and 200 mL (as net content).
Rx
Rhydburg Pharmaceuticals Ltd.India
Khriz Pharma Trading, Inc.
DRP-10805
Nov 25, 2026
PilltuloseLactulose
3.33 g / 5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cap x 120 mL (Box of 1's)
Rx
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-9183-04
Sep 30, 2030
ProlacLactulose
3.33 g / 5mL Oral SolutionAmber PET Bottle with 10 mL Plastic Measuring Cup x 120 mL (Box of 1's)
Rx
Magbro Healthcare Pvt. Ltd.India
Pro Medica Inc.Importer: Pharmakon Biotec Inc.
DRP-9124-13
Sep 4, 2030
RetalacLactulose
3.35 g/5mL Oral SolutionAmber PET Bottle With ROPP cap x 100 mL + Measuring Cup (Box of 1's)
Rx
Panacea Biotec Pharma LimitedIndia
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-12458-02
Aug 12, 2027
RexulacLactulose
3.35 g/ 5mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-4815-07
Feb 10, 2027
RifelacLactulose
3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cup x 120 mL (Box of 1's)
Rx
Stallion Laboratories Pvt. Ltd.India
Rifemedica CorporationImporter: Ambica International Corporation
DRP-9183-01
Sep 30, 2030
SeticonLactulose
3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Eliset Pharmaceutical, Inc.Importer: Accesspoint International Trading Inc.
DRP-4815-05
Feb 10, 2027
SialaxLactulose
3.35 g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Asianmeds, Inc.Importer: Accesspoint International Trading, Inc.
DRP-4815-10
Feb 10, 2027
Stal-lactLactulose
3.33 g/5 mL SyrupAmber-colored PET bottle sealed with 25 mm PP cap with 10 mL measuring cap x 60 mL and 120 mL (Box of 1's)
Rx
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-9183
Sep 30, 2030
UnilacLactulose
3.35 g/5 mL Oral SolutionAmber PET Bottle x 120 mL with HDPE screw cap and medicine cup (Box of 1's)
OTC
KCK Pharmaceutical Industries SDN.Malaysia
Greencore Pharma Inc.
DRP-13301
Jan 20, 2028
ZerriloseLactulose
3.35g/5 mL SyrupPET Bottle with Pilfer Proof Cap x 60 mL and 120 mL (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Kodapharm Med Corp.Importer: Accesspoint International Trading Inc.
DRP-4815-04
Feb 10, 2027
ZuloseLactulose
3.33 g/5 mL Oral Solution
Rx
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-9124-02
Sep 4, 2030
(no brand name)Lactulose
3.33 g/5 mL Syrup60 mL and 120 mL Amber-Colored PET Bottle (Box of 1's)
Rx
Global Pharmaceuticals (Pvt.) Ltd.Pakistan
Surestep Pharmaceuticals, Inc.
DR-XY49439
Jul 2, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

WARNINGS A theoretical hazard may exist for patients being treated with lactulose who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H 2 gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution.

Insufflation of CO 2 as an additional safeguard may be pursued but is considered to be a redundant measure.

Drug interactions

Drug interactions (US label) US FDA label

Drug Interactions Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH. Therefore, a possible lack of desired effect of treatment should be taken into consideration before such drugs are given concomitantly with lactulose.

Adverse reactions

Adverse reactions (US label) US FDA label

ADVERSE REACTIONS Precise frequency data are not available. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential complications such as loss of fluids, hypokalemia, and hypernatremia. Nausea and vomiting have been reported.

Pregnancy considerations

Pregnancy (US label) US FDA label

Pregnancy Teratogenic Effects Reproduction studies have been performed in mice, rats, and rabbits at doses up to 3 or 6 times the usual human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to lactulose. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Breastfeeding considerations

Lactation (US label) US FDA label

Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when lactulose is administered to a nursing woman.

Pharmacokinetics

Half-life and elimination (verbatim, US label)

Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.

Pharmacokinetics (US label) US FDA label

CLINICAL PHARMACOLOGY LACTULOSE is poorly absorbed from the gastro-intestinal tract and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of lactulose reach the colon virtually unchanged. In the colon, lactulose is broken down primarily to lactic acid, and also to small amounts of formic and acetic acids, by the action of colonic bacteria, which results in an increase in osmotic pressure and slight acidification of the colonic contents.

This in turn causes an increase in stool water content and softens the stool. Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24 to 48 hours may be required to produce desired bowel movement. Lactulose given orally to man and experimental animals resulted in only small amounts reaching the blood.

Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Lactulose 3.3 g/5 mL, 120 mL Syrup₱55.00–₱200.00Reference ₱92.50per unitDPRI procurement range
Lactulose 3.35 g/5 mL, 120 mL Syrup₱65.00–₱108.33Reference ₱86.67per unitDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Lactulose
PNF listingOral: 3.3 g/5 mL (3.35 g/5 mL) syrup
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Lactulose · Foxland Pharmaceuticals, Inc. [US FDA-approved label, version 10, October 15, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3363bdbd-f0d1-45b3-8193-7fdb0a310cc2
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .